Search
-
News
Researchers at Memorial Sloan Kettering are developing a new strategy for PET imaging of tumors that could result in new tools to detect and monitor prostate cancer.
… Thursday, November 15, 2012 Summary Researchers at Memorial Sloan Kettering are developing a new strategy for PET imaging of tumors that could result in new tools to detect and monitor prostate cancer. A Memorial Sloan Kettering research team is developing a medical imaging agent that could result in
-
News
The effects of adoptive T cell therapy on mesothelioma and metastatic lung and breast cancers are the focus of a new Memorial Sloan Kettering Cancer Center trial, which, compared to some existing trials of therapy, offers some important differences for patients.
… Friday, September 23, 2016 The Thoracic Surgery Service at Memorial Sloan Kettering Cancer Center (MSK) is excited to announce the opening of a new clinical trial that uses an adoptive T cell therapy approach to treat mesothelioma and metastatic lung and breast cancers. The CAR T Cell Immunotherapy Breakthrough
-
News
Maria Jasin, a member of the Sloan Kettering Institute’s Developmental Biology Program, discusses her research.
… Wednesday, September 25, 2019 Summary Biologist Maria Jasin discusses her work on DNA repair and why the Sloan Kettering Institute is such a great place to do research. On September 25, Sloan Kettering Institute researcher Maria Jasin was presented with the Shaw Prize in Life Science and Medicine at
-
News
This year, the GSK student-run Experimental Therapeutics Symposium highlighted MSK’s expertise in successfully moving novel therapies from bench to bedside.
… Monday, November 7, 2016 Attendees of the Experimental Therapeutics Symposium came from the five former Howard Hughes Medical Institute Med into Grad grant recipient institutions. Attendees of the Experimental Therapeutics Symposium came from the five former Howard Hughes Medical Institute Med into Grad
-
News
A new lung cancer research center has been created at Memorial Sloan Kettering Cancer Center (MSK). The Fiona and Stanley Druckenmiller Center for Lung Cancer Research (DCLCR) is a multidisciplinary research initiative dedicated to developing innovative and more-effective treatments for people with lung cancer.
… Thursday, July 9, 2015 A new lung cancer research center has been created at Memorial Sloan Kettering Cancer Center (MSK). The Fiona and Stanley Druckenmiller Center for Lung Cancer Research (DCLCR) is a multidisciplinary research initiative dedicated to developing innovative and more-effective treatments
-
News
Learn how new research and clinical trials at Memorial Sloan Kettering Cancer Center (MSK) have helped 32-year-old Giancarlo Oviedo-Mori survive — and thrive — with advanced lung cancer for 15 years.
… Monday, March 10, 2025 It was a hot, humid night in 2010 when Giancarlo Oviedo-Mori and his parents sat in a Bronx hospital and received the shock of their lives. They learned that he had advanced non-small cell lung cancer . He was only 18 years old and had big dreams. “Every South American kid wants
-
News
Obtenga información sobre cómo la nueva investigación y los ensayos clínicos en el Memorial Sloan Kettering Cancer Center (MSK) han ayudado a Giancarlo Oviedo-Mori, de 32 años, a sobrevivir, y prosperar, con cáncer pulmonar avanzado durante 15 años.
… Monday, March 10, 2025 Una noche calurosa y húmeda de 2010, Giancarlo Oviedo-Mori y sus padres recibieron la sorpresa más impactante de sus vidas mientras estaban sentados en un hospital del Bronx. Se enteraron de que Giancarlo padecía un cáncer pulmonar avanzado de células no pequeñas . Tenía tan solo
-
News
What proportion of cancer patients are eligible to benefit from precision oncology? There is an ongoing debate on this issue, partly due to a lack of consensus on which gene mutations are clinically actionable.
… Wednesday, October 18, 2023 What proportion of cancer patients are eligible to benefit from precision oncology? There is an ongoing debate on this issue, partly due to a lack of consensus on which gene mutations are clinically actionable. To answer the question, researchers at Memorial Sloan Kettering
-
News
Experts at Memorial Sloan Kettering Cancer Center reviewed the research and found that whole food plant based diets are better than ketogenic diets at reducing cancer risk and helping people after cancer treatment live healthier lives.
… Monday, July 25, 2022 People have sought answers about the relationship between nutrition and health throughout history. In the past few decades, scientific research has uncovered important insights about our diets and cancer, including how food can affect our risk of developing the disease, the treatment
-
News
Called NEXT, the factor plays an important role in handing over RNA to the exosome for destruction.
… Thursday, June 9, 2022 In biology, getting rid of stuff can be just as important as making it. A buildup of cells, proteins, or other molecules that are no longer needed can cause problems, so living things have evolved several ways to clean house. A prime example is the RNA exosome. RNA molecules perform